TY  - JOUR 
AU  - Novillo, Apolonia
AU  - Fernández-Santander, Ana
AU  - Gaibar Alonso, María
AU  - Galán, Miguel
AU  - Romero-Lorca, Alicia
AU  - El Abdellaoui-Soussi, Fadoua
AU  - Gómez del Arco, Pablo
PY  - 2021
UR  - http://hdl.handle.net/20.500.12020/1823
AB  - Chromodomain-helicase-DNA-binding protein 4 (CHD4) is an epigenetic regulator identified as an oncogenic element that may provide a novel therapeutic target for the treatment of breast cancer (BC). CHD4—the core component of the nucleosome remodeling...
LA  - en
PB  - Frontiers
TI  - Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer
DO  - https://doi.org/10.3389/fonc.2021.633233
T2  - Frontiers in Oncology
M2  - 1
KW  - CHD4 gene
KW  - Breast cancer
KW  - Mutation
KW  - Therapies in breast cancer
KW  - Chromatin remodeling
VL  - 11
ER  -